These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

246 related items for PubMed ID: 10460920

  • 1. Formulation strategies for the stabilization of tetanus toxoid in poly(lactide-co-glycolide) microspheres.
    Sánchez A, Villamayor B, Guo Y, McIver J, Alonso MJ.
    Int J Pharm; 1999 Aug 20; 185(2):255-66. PubMed ID: 10460920
    [Abstract] [Full Text] [Related]

  • 2. Improved immunogenicity of a core-coated tetanus toxoid delivery system.
    Tobío M, Schwendeman SP, Guo Y, McIver J, Langer R, Alonso MJ.
    Vaccine; 1999 Nov 12; 18(7-8):618-22. PubMed ID: 10547420
    [Abstract] [Full Text] [Related]

  • 3. Development of a single dose tetanus toxoid formulation based on polymeric microspheres: a comparative study of poly(D,L-lactic-co-glycolic acid) versus chitosan microspheres.
    Jaganathan KS, Rao YU, Singh P, Prabakaran D, Gupta S, Jain A, Vyas SP.
    Int J Pharm; 2005 Apr 27; 294(1-2):23-32. PubMed ID: 15814228
    [Abstract] [Full Text] [Related]

  • 4. Tetanus toxoid microspheres consisting of biodegradable poly(lactide-co-glycolide)- and ABA-triblock-copolymers: immune response in mice.
    Jung T, Koneberg R, Hungerer KD, Kissel T.
    Int J Pharm; 2002 Mar 02; 234(1-2):75-90. PubMed ID: 11839439
    [Abstract] [Full Text] [Related]

  • 5. Chronic local tissue reactions, long-term immunogenicity and immunologic priming of mice and guinea pigs to tetanus toxoid encapsulated in biodegradable polymer microspheres composed of poly lactide-co-glycolide polymers.
    Gupta RK, Alroy J, Alonso MJ, Langer R, Siber GR.
    Vaccine; 1997 Nov 02; 15(16):1716-23. PubMed ID: 9364673
    [Abstract] [Full Text] [Related]

  • 6. A novel system based on a poloxamer/PLGA blend as a tetanus toxoid delivery vehicle.
    Tobío M, Nolley J, Guo Y, McIver J, Alonso MJ.
    Pharm Res; 1999 May 02; 16(5):682-8. PubMed ID: 10350011
    [Abstract] [Full Text] [Related]

  • 7. Tetanus toxoid loaded nanoparticles from sulfobutylated poly(vinyl alcohol)-graft-poly(lactide-co-glycolide): evaluation of antibody response after oral and nasal application in mice.
    Jung T, Kamm W, Breitenbach A, Hungerer KD, Hundt E, Kissel T.
    Pharm Res; 2001 Mar 02; 18(3):352-60. PubMed ID: 11442276
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Erythropoietin loaded microspheres prepared from biodegradable LPLG-PEO-LPLG triblock copolymers: protein stabilization and in-vitro release properties.
    Morlock M, Kissel T, Li YX, Koll H, Winter G.
    J Control Release; 1998 Dec 04; 56(1-3):105-15. PubMed ID: 9801434
    [Abstract] [Full Text] [Related]

  • 11. Stabilization of tetanus toxoid encapsulated in PLGA microspheres.
    Jiang W, Schwendeman SP.
    Mol Pharm; 2008 Dec 04; 5(5):808-17. PubMed ID: 18710256
    [Abstract] [Full Text] [Related]

  • 12. Stabilization of tetanus toxoid in poly(DL-lactic-co-glycolic acid) microspheres for the controlled release of antigen.
    Chang AC, Gupta RK.
    J Pharm Sci; 1996 Feb 04; 85(2):129-32. PubMed ID: 8683435
    [Abstract] [Full Text] [Related]

  • 13. Biodegradable microspheres as controlled-release tetanus toxoid delivery systems.
    Alonso MJ, Gupta RK, Min C, Siber GR, Langer R.
    Vaccine; 1994 Mar 04; 12(4):299-306. PubMed ID: 8178550
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Improving stability and release kinetics of microencapsulated tetanus toxoid by co-encapsulation of additives.
    Johansen P, Men Y, Audran R, Corradin G, Merkle HP, Gander B.
    Pharm Res; 1998 Jul 04; 15(7):1103-10. PubMed ID: 9688067
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Strategies for stabilising tetanus toxoid towards the development of a single-dose tetanus vaccine.
    Schwendeman SP, Costantino HR, Gupta RK, Tobio M, Chang AC, Alonso MJ, Siber GR, Langer R.
    Dev Biol Stand; 1996 Jul 04; 87():293-306. PubMed ID: 8854030
    [Abstract] [Full Text] [Related]

  • 19. In vivo distribution of radioactivity in mice after injection of biodegradable polymer microspheres containing 14C-labeled tetanus toxoid.
    Gupta RK, Chang AC, Griffin P, Rivera R, Siber GR.
    Vaccine; 1996 Oct 04; 14(15):1412-6. PubMed ID: 8994315
    [Abstract] [Full Text] [Related]

  • 20. Protein encapsulation and release from poly(lactide-co-glycolide) microspheres: effect of the protein and polymer properties and of the co-encapsulation of surfactants.
    Blanco D, Alonso MJ.
    Eur J Pharm Biopharm; 1998 May 04; 45(3):285-94. PubMed ID: 9653633
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.